Last Friday, BGm announced the acquisition of two AIFU subsidiaries, including the core assets behind the “Du Xiao Bao” platform. BGm, a global pharma and chemicals giant, has been aggressively pivoting toward AI, especially in enterprise-level cost optimization. This acquisition strategically positions BGm in the high-potential insurance and health sectors while aligning with the second phase of AI adoption. The market recognized this bold move, sending BGm shares up over 20% following the announcement.
Nick44444444 : 照抄?
大牛逼 Nick44444444 : 抄美投君的
71079603 : 還以爲是美投君的馬甲呢
USCY : 要點臉麼?出處都不寫,然後假裝是原創?